Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia

Infection and Immunity

Volumn 80, Issue 4, 2012, Pages 1424-1436

  Murdock, Benjamin J ^a   Falkowski, Nicole R ^a   Shreiner, Andrew B ^a   Sadighi Akha, Amir A ^a   McDonald, Roderick A ^a   White, Eric S ^a   Toews, Galen B ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BONE MARROW; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONIDIUM; CONTROLLED STUDY; EOSINOPHIL; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; FUNGUS SPORE; IMMUNOLOGY; LUNG; LUNG ASPERGILLOSIS; MOUSE MUTANT; PATHOGENICITY; PNEUMONIA; TH17 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD4; ASPERGILLUS FUMIGATUS; EOSINOPHILS; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; PULMONARY ASPERGILLOSIS; PULMONARY EOSINOPHILIA; SPORES, FUNGAL; TH17 CELLS; TH2 CELLS;

EID: 84860791158     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05529-11     Document Type: Article

References (72)

1. Al-Ramli W, et al. 2009. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 123:1185-1187.
2. Angkasekwinai P, et al. 2007. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204:1509 -1517.
3. Barczyk A, Pierzchala W, Sozanska E. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97:726 -733.
4. Bettelli E, Korn T, Oukka M, Kuchroo VK. 2008. Induction and effector functions of T(H)17 cells. Nature 453:1051-1057.
5. Chakir J, et al. 2003. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111: 1293-1298.
6. Cheung PF, Wong CK, Lam CW. 2008. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 180:5625-5635.
7. Ciprandi G, et al. 2009. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 64:1375-1378.
8. Claudio E, et al. 2009. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J. Immunol. 182:1617- 1630.
9. Cohn L, Elias JA, Chupp GL. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789-815.
10. Cruz A, et al. 2006. IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177:1416 -1420.
11. El-behi M, Rostami A, Ciric B. 2010. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5:189 -197.
12. Feng G, et al. 2008. Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur. J. Immunol. 38:2512-2527.
13. Fulkerson PC, Fischetti CA, Rothenberg ME. 2006. Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. Am. J. Pathol. 169:2117-2126.
14. Gafa V, et al. 2006. Human dendritic cells following Aspergillus fumigatus infection express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 cytokines, which lead to a Th1 response. Infect. Immun. 74:1480 -1489.
15. Gerosa F, et al. 2008. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205:1447- 1461.
16. Goodley JM, Clayton YM, Hay RJ. 1994. Environmental sampling for aspergilli during building construction on a hospital site. J. Hosp. Infect. 26:27-35.
17. Happel KI, et al. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761-769.
18. Hellings PW, et al. 2003. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28:42-50.
19. Huffnagle GB, Boyd MB, Street NE, Lipscomb MF. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
20. Humbles AA, et al. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. U. S. A. 99:1479- 1484.
21. Kawaguchi M, et al. 2001. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol. 167:4430-4435.
22. Kawaguchi M, et al. 2006. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J. Allergy Clin. Immunol. 117:795- 801.
23. Khader SA, et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369 -377.
24. Kitani A, Xu L. 2008. Regulatory T cells and the induction of IL-17. Mucosal Immunol. 1(Suppl. 1):S43-S46.
25. Kleinschek MA, et al. 2006. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 176:1098 -1106.
26. Kleinschek MA, et al. 2007. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204:161-170.
27. Latge JP. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310 -350.
28. Linden A, Laan M, Anderson GP. 2005. Neutrophils, interleukin-17A and lung disease. Eur. Respir. J. 25:159 -172.
29. Liu LY, et al. 2002. Decreased expression of membrane IL-5 receptor alpha on human eosinophils. II. IL-5 down-modulates its receptor via a proteinase-mediated process. J. Immunol. 169:6459-6466.
30. Ma W, et al. 2002. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J. Clin. Invest. 109:621- 628.
31. Mangan PR, et al. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231-234.
32. McNagny K, Graf T. 2002. Making eosinophils through subtle shifts in transcription factor expression. J. Exp. Med. 195:F43-F47.
33. Molet S, et al. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108:430-438.
34. Murdock BJ, et al. 2011. Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect. Immun. 79:125-135.
35. Nakae S, et al. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387.
36. Nikolic T, de Bruijn MF, Lutz MB, Leenen PJ. 2003. Developmental stages of myeloid dendritic cells in mouse bone marrow. Int. Immunol. 15:515-524.
37. Noverr MC, Cox GM, Perfect JR, Huffnagle GB. 2003. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71:1538 -1547.
38. Obata K, et al. 2007. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 110:913-920.
39. Oboki K, Ohno T, Saito H, Nakae S. 2008. Th17 and allergy. Allergol. Int. 57:121-134.
40. Ohnmacht C, Pullner A, van Rooijen N, Voehringer D. 2007. Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity. J. Immunol. 179:4766-4774.
41. Osterholzer JJ, et al. 2009. Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J. Immunol. 183: 8044-8053.
42. Owyang AM, et al. 2006. Interleukin 25 regulates type 2 cytokinedependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203:843- 849.
43. Park H, et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
44. Park SJ, et al. 2009. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation. J. Immunol. 183:3259 -3267.
45. Ponath PD, et al. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437-2448.
46. Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME. 2005. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J. Immunol. 175:5341-5350.
47. Radhakrishnan S, et al. 2008. Reprogrammed FoxP3+ T regulatory cellsbecome IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J. Immunol. 181:3137-3147.
48. Rahman MS, et al. 2006. IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J. Immunol. 177:4064-4071.
49. Rickel EA, et al. 2008. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 181: 4299-4310.
50. Robinson DS. 2010. The role of the T cell in asthma. J. Allergy Clin. Immunol. 126:1081-1093.
51. Romani L, et al. 2009. Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus. Med. Mycol. 47(Suppl. 1):S154 -S161.
52. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. 2008. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol. 180:5157-5162.
53. Sanderson CJ. 1992. Interleukin-5, eosinophils, and disease. Blood 79: 3101-3109.
54. Schnyder-Candrian S, et al. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203:2715-2725.
55. Shahrara S, Pickens SR, Dorfleutner A, Pope RM. 2009. IL-17 induces monocyte migration in rheumatoid arthritis. J. Immunol. 182:3884 - 3891.
56. Shreiner AB, et al. 2012. Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10. Infect. Immun. 80:388 -397.
57. Sivick KE, Schaller MA, Smith SN, Mobley HL. 2010. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J. Immunol. 184:2065-2075.
58. Sokol CL, Barton GM, Farr AG, Medzhitov R. 2008. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 9:310 -318.
59. Song C, et al. 2008. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol. 181:6117- 6124.
60. Stevens WW, Kim TS, Pujanauski LM, Hao X, Braciale TJ. 2007. Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J. Immunol. Methods 327:63-74.
61. Stockinger B, Veldhoen M, Martin B. 2007. Th17 T cells: linking innate and adaptive immunity. Semin. Immunol. 19:353-361.
62. Tamachi T, Maezawa Y, Ikeda K, Iwamoto I, Nakajima H. 2006. Interleukin 25 in allergic airway inflammation. Int. Arch. Allergy Immunol. 140(Suppl. 1):59-62.
63. Tamachi T, et al. 2006. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J. Allergy Clin. Immunol. 118:606-614.
64. Tesmer LA, Lundy SK, Sarkar S, Fox DA. 2008. Th17 cells in human disease. Immunol. Rev. 223:87-113.
65. van der Loo JC, Slieker WA, Kieboom D, Ploemacher RE. 1995. Identification of hematopoietic stem cell subsets on the basis of their primitiveness using antibody ER-MP12. Blood 85:952-962.
66. von Vietinghoff S, Ley K. 2009. IL-17A controls IL-17F production and maintains blood neutrophil counts in mice. J. Immunol. 183:865- 873.
67. Wakashin H, et al. 2008. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 178:1023-1032.
68. Yang XO, et al. 2008. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205:1063-1075.
69. Yu C, et al. 2002. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195:1387-1395.
70. Zelante T, et al. 2009. Th17 cells in the setting of Aspergillus infection and pathology. Med. Mycol. 47(Suppl. 1):S162-S169.
71. Zelante T, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695- 2706.
72. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. 2003. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J. Allergy Clin. Immunol. 111:227-242.